Amarin Corp Stock (NASDAQ: AMRN) stock price, news, charts, stock research, profile.
Open | $0.880 |
Close | - |
Volume / Avg. | 155.801K / 2.236M |
Day Range | 0.880 - 0.899 |
52 Wk Range | 0.651 - 1.580 |
Market Cap | $364.430M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 4.19% |
Days to Cover | 14.33 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Amarin Corp (NASDAQ: AMRN) through any online brokerage.
Other companies in Amarin Corp’s space includes: Renovaro (NASDAQ:RENB), Humacyte (NASDAQ:HUMA), Adverum Biotechnologies (NASDAQ:ADVM), Precigen (NASDAQ:PGEN) and Inovio Pharmaceuticals (NASDAQ:INO).
The latest price target for Amarin Corp (NASDAQ: AMRN) was reported by JP Morgan on Monday, November 20, 2023. The analyst firm set a price target for 0.00 expecting AMRN to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Amarin Corp (NASDAQ: AMRN) is $0.88 last updated Today at March 28, 2024 at 10:31 AM EDT.
There are no upcoming dividends for Amarin Corp.
Amarin Corp’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Amarin Corp.
Amarin Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.